Works matching IS 09024441 AND DT 2017 AND VI 99 AND IP 5


Results: 13
    1
    2
    3
    4
    5

    Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.

    Published in:
    European Journal of Haematology, 2017, v. 99, n. 5, p. 409, doi. 10.1111/ejh.12923
    By:
    • Zagouri, Flora;
    • Kastritis, Efstathios;
    • Zomas, Athanasios;
    • Terpos, Evangelos;
    • Katodritou, Eirini;
    • Symeonidis, Argiris;
    • Delimpasi, Sosana;
    • Pouli, Anastasia;
    • Vassilakopoulos, Theodoros P.;
    • Michalis, Eurydiki;
    • Giannouli, Stavroula;
    • Kartasis, Zafiris;
    • Christoforidou, Anna;
    • Kokoviadou, Kiriaki;
    • Hatzimichael, Eleftheria;
    • Gika, Dimitra;
    • Megalakaki, Catherine;
    • Papaioannou, Maria;
    • Kyrtsonis, Marie‐Christine;
    • Konstantopoulos, Kostas
    Publication type:
    Article
    6
    7

    Issue Information.

    Published in:
    European Journal of Haematology, 2017, v. 99, n. 5, p. 383, doi. 10.1111/ejh.12804
    Publication type:
    Article
    8
    9
    10
    11
    12
    13